Dendreon Corp fka DNDNQ

[walldiver]

OT-GTOP...I have little confidence the Phase III will succeed. Stat sig hurdle for the final data is approx 0.025. They already missed stat sig on both of the two interim looks. However, not much that has happened in 2007 in development-stage biotech has been true to form. So, I could very well be wrong, and all of those biotech hedge funds that make a ton of money by betting on negative Phase 3 results from development-stage biotechs (including GTOP) could wrong as well. Just remember that you're getting an opinion from someone who believed the SNUS Phase 3 would succeed based on stellar Phase 2 data, and thought the FDA would almost certainly approve Provenge after the thumbs up from CTGTAC.